PhD Candidate
University of California Santa Barbara
Meg Schimmel, B.S. and M.A., is a dedicated researcher and a 6th-year Ph.D. candidate at UCSB in the Weimbs lab, where they investigate the molecular mechanisms and potential therapeutic strategies for polycystic kidney disease (PKD). Her academic journey began with a strong foundation in molecular & cellular biology during her undergraduate studies, followed by a specific focus on pharmacology and biotechnology in her master's degree; both of which Meg continues to build upon in her current research.
Originally from the coastal town of Carmel, CA, Meg has spent the last decade in Santa Barbara, immersing herself in scientific exploration and the vibrant community of researchers at UCSB. Her passion for science extends beyond the PKD space, as she is deeply committed to developing innovative approaches that can reduce the reliance on animal testing in drug development for her future career path. Meg envisions a future where novel pharmaceutical compounds can be rigorously tested using advanced biological systems, minimizing the need for animal studies and alleviating the suffering of laboratory animals.
In addition to her academic pursuits, Meg finds joy in artistic expression through acrylic painting in her free time. She also cherishes the simple pleasures of life, often enjoying leisurely walks on the beach with her dog, Zola.
As Meg prepares to present her research poster at the AAPS National Biotechnology Conference, she is eager to share her findings and collaborate with fellow researchers in the field. By focusing on advancing scientific knowledge as well as encouraging the development of novel drug-testing platforms, Meg is poised to make a significant impact in the realm of biotechnology and drug development.